Ana Bosch
Lund, M, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Homologous recombination deficiency in primary ER-positive and HER2-negative breast cancer.
Journal: Communications medicine
Published: September 15, 2025
Evaluation of alternative prognostic thresholds for SP142 and 22C3 immunohistochemical PD-L1 expression in triple-negative breast cancer: results from a population-based cohort.
Journal: Breast cancer research and treatment
Published: May 28, 2024
The analytical and clinical validity of AI algorithms to score TILs in TNBC: can we use different machine learning models interchangeably?
Journal: EClinicalMedicine
Published: May 20, 2024
High Caveolin-1 mRNA expression in triple-negative breast cancer is associated with an aggressive tumor microenvironment, chemoresistance, and poor clinical outcome.
Journal: PloS one
Published: February 13, 2024
Caveolin-1 gene expression provides additional prognostic information combined with PAM50 risk of recurrence (ROR) score in breast cancer.
Journal: Scientific reports
Published: December 14, 2023
The role of serum thymidine kinase 1 activity in neoadjuvant-treated HER2-positive breast cancer: biomarker analysis from the Swedish phase II randomized PREDIX HER2 trial.
Journal: Breast cancer research and treatment
Published: July 24, 2023
Comparison of SP142 and 22C3 PD-L1 assays in a population-based cohort of triple-negative breast cancer patients in the context of their clinically established scoring algorithms.
Journal: Breast cancer research : BCR
Published: April 20, 2023
Caveolin-1 genotypes as predictor for locoregional recurrence and contralateral disease in breast cancer.
Journal: Breast cancer research and treatment
Published: November 28, 2022
Survival Outcomes, Digital TILs, and On-treatment PET/CT During Neoadjuvant Therapy for HER2-positive Breast Cancer: Results from the Randomized PREDIX HER2 Trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: September 16, 2022
Interplay between Caveolin-1 and body and tumor size affects clinical outcomes in breast cancer.
Journal: Translational oncology
Published: March 30, 2022
Last Updated: 09/26/2026